NTC is an international R&D-driven pharmaceutical company headquartered in Milan, Italy, with distributors and partners in over 100 countries in the world, engaged in research, development, registration and commercialization of drugs, medical devices, and food supplements in ophthalmology, but also in other therapeutic areas like gastro-metabolism, gynecology, and pediatrics.

NTC is the first Italian pharmaceutical company to launch in ophthalmology an innovative therapeutic solution globally: a drug to appropriately manage the prevention of infection and to treat inflammation in patients after cataract surgery.

NTC offers to its partners, currently nearly 250 companies, innovative pharmaceutical products with high quality standards. In addition to our B2B model, NTC carries out direct commercial activities in Italy and Spain, with field forces entirely focused on Ophthalmology. NTC is controlled by private equity funds: Wise Equity SGR S.p.A., Unigestion GP S.à.r.l., and Racer S.r.l.



Advanced scientific research and technology are the engine of NTC innovation in care practices.

NTC innovation translates into the discovery of new and specific therapeutic gestures that are simpler and more intuitive, sustainable, healthier and technically adequate.

Read more


NTC is making a fresh model of partnership designed to provide solutions to increase the potential and the value of the relationship and to add mutual and competitive advantages for both us and our partners.
Read more

NTC World

Therapeutic Solutions

If research is the soul of NTC, improving the care experience constitutes the essence of its vocational offer. Prior to being realized in the product, research is embodied in the accompanying therapeutic gestures.

Other than constituting the backbone of NTC business, rigorous and diffused experimentations on patients, Scientific Advice, scientific publications and the transparent disclosure of results are a working methodology, which is the essential guiding spirit of the company.

NTC research aims at placing innovation within everyone's reach. NTC product portfolio is broad, mostly in Ophthalmology but diversified in Gynecology, Gastroenterology, and Pediatrics too.

Gastro - Metabolism